ReviewMolecules (Basel, Switzerland)2026
Broadband Coherent Raman Scattering: Excitation Architectures and Operating Regimes.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Coherent Raman scattering (CRS) techniques such as coherent anti-Stokes Raman scattering (CARS) provide chemically specific vibrational contrast with signal levels far exceeding spontaneous Raman scattering (SpRS). Extending these to broadband excitation enables multiplex detection across wide spectral regions, including the fingerprint region, CH-stretch bands and high-frequency vibrational modes. This review provides a structured overview of excitation architecture for broadband CRS, ranging from low-energy oscillator schemes to energy-scalable platforms. The discussion is organized along key design parameters, including spectral bandwidth, excitation intensity, and probe delay, which jointly determine the accessible operating regimes. Rather than representing competing methods, the reviewed architectures are presented as a complementary toolbox for application-driven spectroscopy in chemically reactive environments and complex biological systems. In addition, a representative OPCPA-based implementation is presented as a platform demonstration to illustrate accessible operating regimes, single-shot stability, and multiplex detection capability under realistic experimental conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.